SBFM Sunshine Biopharma Inc. Stock Price

Sunshine Biopharma (SBFM) represents a biotech firm in the clinical trial stage, where growth potential is tied to patents and the outsourcing of production to avoid capital expenditures. The price action on GURU.Markets visualizes this trajectory, with the metric standing at 2.67. The company develops cutting-edge anti-tumor and anti-viral agents by targeting the fundamental life processes of pathogens. Currently, the business is reviewing its development portfolio and optimizing R&D expenses to maintain liquidity.

SBFM - Sunshine Biopharma, Inc. Quote Chart over the range 07/04/2022 - 11/14/2026

Metric breakdowns and analytics for sunshinebiopharma.com (SBFM)

- stock value and consensus price forecast:

Price Chart Sunshine Biopharma|SBFM - Analyst Median Target

- market capitalization data:

Market Capitalization Sunshine Biopharma Inc.|SBFM - Total Company Value

- book capitalization information:

Book Value per Share Sunshine Biopharma|SBFM - Net Asset Value|Market Value to Book Value Ratio sunshinebiopharma.com|SBFM - Cumulative Company Assets

- debt obligations and liquidity statistics:

Total Debt to Capital Sunshine Biopharma|SBFM - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Sunshine Biopharma, Inc.|SBFM - Company Aggregate Debts|Debt to Book Capitalization Ratio Sunshine Biopharma Inc.|SBFM - Company Long-Term Indebtedness|Company Short-Term Debts Sunshine Biopharma|Quick Ratio sunshinebiopharma.com

- earnings and market ratios statistics:

SBFM - Company Net Income|Expected Profit Sunshine Biopharma|SBFM - Company Value to Net Income|Projected Price to Earnings Sunshine Biopharma|SBFM - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Sunshine Biopharma Inc.|SBFM - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Sunshine Biopharma|SBFM - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months sunshinebiopharma.com|SBFM - Earnings per share increase in current year|Earnings growth forecast for next year Sunshine Biopharma

- sales and revenue indicators:

SBFM - Company Total Revenue|Company Projected Revenue Sunshine Biopharma, Inc.|SBFM - Price-to-Revenue Coefficient|Forward Price-to-Revenue Multiple Sunshine Biopharma Inc.

Comprehensive company analysis:SBFM Sunshine Biopharma

The price reflects the current market value of a single SBFM share, consolidating investor expectations regarding future cash flows and the fundamental value of the business. When analyzing the securities' price history, it should be noted that Sunshine Biopharma quotes are sensitive to geopolitical risks affecting the stability of reagent supplies and the success of international clinical trials.

Who Sunshine Biopharma competes with